10-K Filing

GLUCOSE HEALTH, INC. CIK: 1420108 FY 2013

Filing Information

Form Type	10-K
Accession Number	`0001477932-14-003318`
Period End Date	20131231
Filing Date	20140625
Fiscal Year	2013
Fiscal Period	FY
XBRL Instance	bisu-20131231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 49 Income Statement 54 Cash Flow Statement 56 Stockholders Equity 29

Balance Sheet 49 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`Cash`	$711.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash	`Cash`	$1.08K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	18.87M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	10.11M	shares	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Inventory	`InventoryNet`	$24.88K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$25.59K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	10.11M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.08K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	18.87M	shares	Point-in-time
Intellectual Property	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$206.60K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$25.59K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$207.68K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$123.20K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$144.63K	USD	Point-in-time
Short - term loans	`NotesPayableCurrent`	-	USD	Point-in-time
Short - term loans	`NotesPayableCurrent`	$6.00K	USD	Point-in-time
Short - term loans - related parties	`DueToRelatedPartiesCurrent`	$1.60K	USD	Point-in-time
Short - term loans - related parties	`DueToRelatedPartiesCurrent`	$1.67K	USD	Point-in-time
Short - term loans - convertible	`ConvertibleNotesPayableCurrent`	$71.04K	USD	Point-in-time
Short - term loans - convertible	`ConvertibleNotesPayableCurrent`	$60.68K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$185.48K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$223.35K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$185.48K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$223.35K	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized, 18,872,777 and 10,108,586 shares issued and outstanding as of December 31, 2013 and 2012, respectively (1)	`CommonStockValue`	$18.87K	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized, 18,872,777 and 10,108,586 shares issued and outstanding as of December 31, 2013 and 2012, respectively (1)	`CommonStockValue`	$10.11K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$3.68M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$4.74M	USD	Point-in-time
Stock to be issued	`StockToBeIssued`	-	USD	Point-in-time
Stock to be issued	`StockToBeIssued`	$34.40K	USD	Point-in-time
Deferred Compensation	`DeferredCompensationLiabilityCurrent`	$-150.00K	USD	Point-in-time
Deferred Compensation	`DeferredCompensationLiabilityCurrent`	$-17.37K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.87M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.87M	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$2.03M	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$568.65K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-75.28K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-75.28K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$22.20K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-310.14K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-186.02K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-197.76K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$25.59K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$207.68K	USD	Point-in-time

Income Statement 54 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`SalesRevenueGoodsNet`	-	USD	Annual
REVENUE	`SalesRevenueGoodsNet`	$-224.00	USD	9 Qtrs
REVENUE	`SalesRevenueGoodsNet`	$-224.00	USD	Annual
COST OF REVENUES	`CostOfRevenue`	-	USD	Annual
COST OF REVENUES	`CostOfRevenue`	$5.95K	USD	9 Qtrs
COST OF REVENUES	`CostOfRevenue`	$2.31K	USD	Annual
GROSS LOSS	`GrossProfit`	$-5.72K	USD	9 Qtrs
GROSS LOSS	`GrossProfit`	$-2.09K	USD	Annual
Professional fees/stock based compensation	`SalariesAndWages`	$355.66K	USD	Annual
Professional fees/stock based compensation	`SalariesAndWages`	$1.46M	USD	9 Qtrs
Professional fees/stock based compensation	`SalariesAndWages`	$1.03M	USD	Annual
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	$285.29K	USD	9 Qtrs
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	$200.00K	USD	Annual
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	-	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$5.77K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$39.50K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$45.77K	USD	9 Qtrs
Total operating expenses	`OperatingExpenses`	$1.27M	USD	Annual
Total operating expenses	`OperatingExpenses`	$361.42K	USD	Annual
Total operating expenses	`OperatingExpenses`	$1.80M	USD	9 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-1.27M	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-361.42K	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-1.80M	USD	9 Qtrs
Interest income (expense)	`InterestExpense`	$205.03K	USD	9 Qtrs
Interest income (expense)	`InterestExpense`	$37.66K	USD	Annual
Interest income (expense)	`InterestExpense`	$168.86K	USD	Annual
Loss on conversion of debt	`DebtConversionOriginalDebtAmount1`	-	USD	Annual
Loss on conversion of debt	`DebtConversionOriginalDebtAmount1`	$-21.00K	USD	Annual
Loss on conversion of debt	`DebtConversionOriginalDebtAmount1`	$-21.00K	USD	9 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-37.66K	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-189.86K	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-226.03K	USD	9 Qtrs
LOSS BEFORE IMCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.46M	USD	Annual
LOSS BEFORE IMCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.03M	USD	9 Qtrs
LOSS BEFORE IMCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-399.08K	USD	Annual
PROVISION FOR (BENEFIT FROM) INCOME TAXES	`IncomeTaxExpenseBenefit`	-	USD	Annual
PROVISION FOR (BENEFIT FROM) INCOME TAXES	`IncomeTaxExpenseBenefit`	-	USD	Annual
PROVISION FOR (BENEFIT FROM) INCOME TAXES	`IncomeTaxExpenseBenefit`	-	USD	9 Qtrs
NET LOSS	`NetIncomeLoss`	$-1.46M	USD	Annual
NET LOSS	`NetIncomeLoss`	$-2.03M	USD	9 Qtrs
NET LOSS	`NetIncomeLoss`	$-399.08K	USD	Annual
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED (2)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.61M	shares	Annual
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED (2)	`WeightedAverageNumberOfSharesOutstandingBasic`	14.86M	shares	Annual
NET LOSS PER SHARE - BASIC AND DILUTED	`EarningsPerShareBasic`	$-0.05	USD	Annual
NET LOSS PER SHARE - BASIC AND DILUTED	`EarningsPerShareBasic`	$-0.10	USD	Annual
Net loss	`NetIncomeLoss`	$-1.46M	USD	Annual
Net loss	`NetIncomeLoss`	$-2.03M	USD	9 Qtrs
Net loss	`NetIncomeLoss`	$-399.08K	USD	Annual
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-12.58K	USD	9 Qtrs
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-6.06K	USD	Annual
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	-	USD	Annual
TOTAL COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-2.04M	USD	9 Qtrs
TOTAL COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-405.14K	USD	Annual
TOTAL COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-1.46M	USD	Annual

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.46M	USD	Annual
Net loss	`NetIncomeLoss`	$-2.03M	USD	9 Qtrs
Net loss	`NetIncomeLoss`	$-399.08K	USD	Annual
Impairment expense	`AssetImpairmentCharges`	$200.00K	USD	Annual
Impairment expense	`AssetImpairmentCharges`	$285.29K	USD	9 Qtrs
Impairment expense	`AssetImpairmentCharges`	-	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$925.68K	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$1.28M	USD	9 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$259.18K	USD	Annual
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	$-172.97K	USD	Annual
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	$-34.30K	USD	Annual
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	$-207.27K	USD	9 Qtrs
Loss on conversion of debt	`DebtConversionOriginalDebtAmount1`	-	USD	Annual
Loss on conversion of debt	`DebtConversionOriginalDebtAmount1`	$-21.00K	USD	Annual
Loss on conversion of debt	`DebtConversionOriginalDebtAmount1`	$-21.00K	USD	9 Qtrs
Increase in inventory	`IncreaseDecreaseInInventories`	$24.88K	USD	9 Qtrs
Increase in inventory	`IncreaseDecreaseInInventories`	-	USD	Annual
Increase in inventory	`IncreaseDecreaseInInventories`	$24.88K	USD	Annual
Increase in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$32.39K	USD	Annual
Increase in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$21.92K	USD	Annual
Increase in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$40.40K	USD	9 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$315.39K	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$1.33M	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$1.81M	USD	9 Qtrs
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-131.99K	USD	Annual
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-83.69K	USD	Annual
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-220.68K	USD	9 Qtrs
Proceeds from notes and loans payable	`ProceedsFromNotesAndLoansPayable`	$-78.60K	USD	Annual
Proceeds from notes and loans payable	`ProceedsFromNotesAndLoansPayable`	$-134.22K	USD	Annual
Proceeds from notes and loans payable	`ProceedsFromNotesAndLoansPayable`	$-214.55K	USD	9 Qtrs
Principal payments on notes and loans payable	`PrincipalPaymentsOnNotesAndLoansPayable`	$-2.60K	USD	Annual
Principal payments on notes and loans payable	`PrincipalPaymentsOnNotesAndLoansPayable`	$-2.60K	USD	9 Qtrs
Principal payments on notes and loans payable	`PrincipalPaymentsOnNotesAndLoansPayable`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$78.60K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$211.95K	USD	9 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$131.62K	USD	Annual
Effect of exchange rates on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$6.08K	USD	Annual
Effect of exchange rates on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$5.51K	USD	9 Qtrs
Effect of exchange rates on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	-	USD	Annual
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$994.00	USD	Annual
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-365.00	USD	Annual
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-3.22K	USD	9 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsAtCarryingValue`	$82.00	USD	Point-in-time
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsAtCarryingValue`	$1.08K	USD	Point-in-time
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsAtCarryingValue`	$3.93K	USD	Point-in-time
CASH - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$711.00	USD	Point-in-time
CASH - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$1.08K	USD	Point-in-time
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$54.28K	USD	Annual
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$131.76K	USD	Annual
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$202.50K	USD	9 Qtrs
Conversion of liability to common stock	`StockIssued1`	$47.80K	USD	Annual
Conversion of liability to common stock	`StockIssued1`	$54.17K	USD	9 Qtrs
Conversion of liability to common stock	`StockIssued1`	$6.38K	USD	Annual
Conversion of accounts payable and notes payable to equity (Note 9)	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$291.56K	USD	9 Qtrs
Conversion of accounts payable and notes payable to equity (Note 9)	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	-	USD	Annual
Conversion of accounts payable and notes payable to equity (Note 9)	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$217.81K	USD	Annual

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquity`	$22.20K	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$-310.14K	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$-186.02K	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$-197.76K	USD	Point-in-time
Common shares issued for services, Amount	`CommonSharesIssuedForServicesAmount`	$10.00K	USD	1 Quarter
Common shares issued for services, Amount	`CommonSharesIssuedForServicesAmount`	$761.05K	USD	Annual
Common shares issued for services, Amount	`CommonSharesIssuedForServicesAmount`	$184.18K	USD	Annual
Common shares issued for settlement of notes payable, Amount	`CommonSharesIssuedForSettlementOfNotesPayableAmount`	$9.86K	USD	1 Quarter
Common shares issued for settlement of notes payable, Amount	`CommonSharesIssuedForSettlementOfNotesPayableAmount`	$54.28K	USD	Annual
Common shares issued for settlement of notes payable, Amount	`CommonSharesIssuedForSettlementOfNotesPayableAmount`	$131.76K	USD	Annual
Common shares issued for Type 2 Acquisition, Amount	`CommonSharesIssuedForType2AcquisitionAmount`	$206.60K	USD	1 Quarter
Conversion of accounts payable to equity	`ConversionOfAccountsPayableToEquity`	$73.75K	USD	1 Quarter
Common shares issued for liability for stock to be issued, Amount	`CommonSharesIssuedForLiabilityForStockToBeIssuedAmount`	$41.50K	USD	Annual
Common shares issued for compensation under employment agreement, Amount	`CommonSharesIssuedForCompensationUnderEmploymentAgreementAmount`	-	USD	Annual
Common shares issued for settlement of accounts payable, Amount	`CommonSharesIssuedForSettlementOfAccountsPayableAmount`	$6.38K	USD	Annual
Common shares issued for settlement of accounts payable, Amount	`CommonSharesIssuedForSettlementOfAccountsPayableAmount`	$6.30K	USD	Annual
Conversion of accounts payable and notes payable to equity (Note 8)	`ConversionOfAccountsPayableAndNotesPayableToEquityNote8`	$217.81K	USD	Annual
Discounts on shares issued for notes payable	`DiscountsOnSharesIssuedForNotesPayable`	$34.30K	USD	Annual
Discounts on shares issued for notes payable	`DiscountsOnSharesIssuedForNotesPayable`	$172.97K	USD	Annual
Amortization of deferred compensation	`AmortizationOfDeferredCompensation`	$75.00K	USD	Annual
Amortization of deferred compensation	`AmortizationOfDeferredCompensation`	$132.63K	USD	Annual
Stock to be issued	`StockToBeIssue`	$34.40K	USD	Annual
Net loss for the year	`ProfitLoss`	$-1.46M	USD	Annual
Net loss for the year	`ProfitLoss`	$-176.09K	USD	1 Quarter
Net loss for the year	`ProfitLoss`	$-405.14K	USD	Annual
Ending Balance, Amount	`StockholdersEquity`	$22.20K	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$-310.14K	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$-186.02K	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$-197.76K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.